154 related articles for article (PubMed ID: 24990613)
1. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.
Weinhold N; Försti A; da Silva Filho MI; Nickel J; Campo C; Hoffmann P; Nöthen MM; Hose D; Goldschmidt H; Jauch A; Langer C; Hegenbart U; Schönland SO; Hemminki K
Leukemia; 2014 Nov; 28(11):2254-6. PubMed ID: 24990613
[No Abstract] [Full Text] [Related]
2. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
da Silva Filho MI; Försti A; Weinhold N; Meziane I; Campo C; Huhn S; Nickel J; Hoffmann P; Nöthen MM; Jöckel KH; Landi S; Mitchell JS; Johnson D; Morgan GJ; Houlston R; Goldschmidt H; Jauch A; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Hemminki K
Leukemia; 2017 Aug; 31(8):1735-1742. PubMed ID: 28025584
[TBL] [Abstract][Full Text] [Related]
4. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
[TBL] [Abstract][Full Text] [Related]
5. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
Gu M; Wilton R; Stevens FJ
Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
[TBL] [Abstract][Full Text] [Related]
6. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
7. A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis.
Katoh N; Poshusta TL; Manske MK; Dispenzieri A; Gertz MA; Abraham RS; Ramirez-Alvarado M
J Clin Immunol; 2011 Dec; 31(6):1029-37. PubMed ID: 21909811
[TBL] [Abstract][Full Text] [Related]
8. Cystic lung disease with kappa light chain deposition in newly diagnosed multiple myeloma.
Clayden RC; Macdonald D; Oikonomou A; Cheung MC
Br J Haematol; 2020 Jan; 188(2):201. PubMed ID: 31625161
[No Abstract] [Full Text] [Related]
9. An unusual case of amyloidosis complicating light chain myeloma.
Handa SI; Sheehan T; Ludlam CA
Acta Haematol; 1991; 86(1):40-1. PubMed ID: 1950361
[TBL] [Abstract][Full Text] [Related]
10. Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.
Abraham RS; Ballman KV; Dispenzieri A; Grill DE; Manske MK; Price-Troska TL; Paz NG; Gertz MA; Fonseca R
Blood; 2005 Jan; 105(2):794-803. PubMed ID: 15388584
[TBL] [Abstract][Full Text] [Related]
11. Comment on amyloid neuropathy in light chain multiple myeloma.
Sommer C; Schröder JM
Clin Neuropathol; 1989; 8(6):307. PubMed ID: 2515930
[No Abstract] [Full Text] [Related]
12. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
[TBL] [Abstract][Full Text] [Related]
13. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.
Nevone A; Girelli M; Mangiacavalli S; Paiva B; Milani P; Cascino P; Piscitelli M; Speranzini V; Cartia CS; Benvenuti P; Goicoechea I; Fazio F; Basset M; Foli A; Nanci M; Mazzini G; Caminito S; Sesta MA; Casarini S; Rognoni P; Lavatelli F; Petrucci MT; Olimpieri PP; Ricagno S; Arcaini L; Merlini G; Palladini G; Nuvolone M
Leukemia; 2022 Aug; 36(8):2076-2085. PubMed ID: 35610346
[TBL] [Abstract][Full Text] [Related]
14. Light-chain deposition disease: its relation with AL-type amyloidosis.
Ganeval D; Noël LH; Preud'homme JL; Droz D; Grünfeld JP
Kidney Int; 1984 Jul; 26(1):1-9. PubMed ID: 6434789
[No Abstract] [Full Text] [Related]
15. [Inclusions fixing thioflavin T in plasmacytes of IgG lambda myeloma with amylosis].
Canioni D; Kermarec J
Arch Anat Cytol Pathol; 1982; 30(5-6):279-83. PubMed ID: 6188417
[No Abstract] [Full Text] [Related]
16. [Fatal subileus caused by intestinal amyloidosis in light chain plasmacytoma].
Verbeke CS; Bohrer MH; Döring A; Lengfelder E
Leber Magen Darm; 1994 Feb; 24(1):36, 39-41. PubMed ID: 8145625
[TBL] [Abstract][Full Text] [Related]
17. Association light chain deposition disease (LCDD) and amyloidosis. One case.
Hofmann-Guilaine C; Nochy D; Jacquot C; Tricottet V; Bariety J; Camilleri JP
Pathol Res Pract; 1985 Aug; 180(2):214-9. PubMed ID: 3932985
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis.
Pfeifer S; Perez-Andres M; Ludwig H; Sahota SS; Zojer N
Leukemia; 2011 Jul; 25(7):1213-6. PubMed ID: 21494259
[No Abstract] [Full Text] [Related]
19. Clinicopathologic and proteomic characteristics of intratubular cytoplasmic AL amyloidosis.
Javaugue V; Rocha AB; Said SM; Santoriello D; Hou J; Dasari S; Theis JD; Vrana JA; Batal I; Larsen C; Markowitz GS; D'Agati VD; McPhail ED; Leung N; Nasr SH
Kidney Int; 2022 Oct; 102(4):926-929. PubMed ID: 35964797
[No Abstract] [Full Text] [Related]
20. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
Abraham RS; Manske MK; Zuckerman NS; Sohni A; Edelman H; Shahaf G; Timm MM; Dispenzieri A; Gertz MA; Mehr R
J Clin Immunol; 2007 Jan; 27(1):69-87. PubMed ID: 17192818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
